Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × tazemetostat × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 6 Sarcoma 3 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Inhibition, Psychological 1 Immunoblastic Lymphadenopathy 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡